Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001662244-19-000002
Filing Date
2019-10-15
Accepted
2019-10-15 11:09:56
Documents
1
Effectiveness Date
2019-10-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9184
  Complete submission text file 0001662244-19-000002.txt   10269
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-350987 | Film No.: 191150096